Abstract
Following infection with 103 cells of Cryptococcus neoformans, progressive multiplication occurred in all tissues for 7 to 28 days. Thereafter, most mice gained control of the infection so that 3 to 6 months after inoculation, tissues were usually sterile or contained only small numbers of cryptococci. Survivors challenged 1 to 4 months after infection with 103 cells lived longer than controls and had an increased survival rate. Pretreatment with bacterial endotoxin also resulted in protection against cryptococcal challenge. Endotoxin-protected animals showed no ability to limit the infection until circulating antibody could be demonstrated. Histologic studies revealed an increased cellular infiltration in the brains of specifically protected and endotoxin-protected mice 1 to 2 weeks after challenge. However, control of cryptococcal multiplication could be correlated with the presence of antibody but could not be correlated with the enhanced cellular response. Although protection against cryptococcal challenge appears to be antibody-dependent, it is unclear whether protective antibody is to be found in plasma or is tissue-bound.
Full Text
The Full Text of this article is available as a PDF (991.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BOEHME D., DUBOS R. J. The effect of bacterial constituents on the resistance of mice to heterologous infection and on the activity of their reticulo-endothelial system. J Exp Med. 1958 Apr 1;107(4):523–536. doi: 10.1084/jem.107.4.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
- COHN Z. A., MORSE S. I. Functional and metabolic properties of polymorphonuclear leucocytes. II. The influence of a lipopolysaccharide endotoxin. J Exp Med. 1960 May 1;111:689–704. doi: 10.1084/jem.111.5.689. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DOUGHERTY R. M., GROUPE V. Studies on nonspecific acquired resistance to viral toxicity in mice. Proc Soc Exp Biol Med. 1957 Jul;95(3):593–596. doi: 10.3181/00379727-95-23303. [DOI] [PubMed] [Google Scholar]
- GADEBUSCH H. H. Active immunization against Cryptococcus neoformans. J Infect Dis. 1958 May-Jun;102(3):219–226. doi: 10.1093/infdis/102.3.219. [DOI] [PubMed] [Google Scholar]
- GADEBUSCH H. H. Passive immunization against Cryptococcus neoformans. Proc Soc Exp Biol Med. 1958 Jul;98(3):611–614. doi: 10.3181/00379727-98-24123. [DOI] [PubMed] [Google Scholar]
- JOHNSON A. G., GAINES S., LANDY M. Studies on the O antigen of Salmonella typhosa. V. Enhancement of antibody response to protein antigens by the purified lipopolysaccharide. J Exp Med. 1956 Feb 1;103(2):225–246. doi: 10.1084/jem.103.2.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LITCHFIELD J. T., Jr, WILCOXON F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther. 1949 Jun;96(2):99–113. [PubMed] [Google Scholar]
- LOURIA D. B. Specific and non-specific immunity in experimental cryptococcosis in mice. J Exp Med. 1960 May 1;111:643–665. doi: 10.1084/jem.111.5.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
- POLLOCK A. Q., WARD L. M. A hemagglutination test for cryptococcosis. Am J Med. 1962 Jan;32:6–16. doi: 10.1016/0002-9343(62)90177-8. [DOI] [PubMed] [Google Scholar]
- SALVIN S. B. Endotoxin in pathogenic q fungi. J Immunol. 1952 Jul;69(1):89–99. [PubMed] [Google Scholar]
- VOGEL R. A., SELLERS T. F., Jr, WOODWARD P. Fluorescent antibody techniques applied to the study of human cryptococcosis. JAMA. 1961 Dec 2;178:921–923. doi: 10.1001/jama.1961.73040480010008d. [DOI] [PubMed] [Google Scholar]
- WHITBY J. L., MICHAEL J. G., WOODS M. W., LANDY M. Symposium on bacterial endotoxins. II. Possible mechanisms whereby endotoxins evoke increased nonspecific resistance to infection. Bacteriol Rev. 1961 Dec;25:437–446. doi: 10.1128/br.25.4.437-446.1961. [DOI] [PMC free article] [PubMed] [Google Scholar]